Prevention, diagnosis, and treatment of tuberculosis in children and mothers: Evidence for action for maternal, neonatal, and child health services

Journal of Infectious Diseases

Volumn 205, Issue SUPPL. 2, 2012, Pages

  Getahun, Haileyesus ^a   Sculier, Delphine ^a   Sismanidis, Charalambos ^a   Grzemska, Malgorzata ^a   Raviglione, Mario ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT; VITAMIN K GROUP;

BREAST FEEDING; CHILD HEALTH CARE; CHILDHOOD TUBERCULOSIS; COUGHING; DIAGNOSTIC PROCEDURE; DISEASE TRANSMISSION; DRUG SAFETY; FEMALE INFERTILITY; FEVER; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH SERVICE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; INFECTION RISK; LIVER TOXICITY; MASS SCREENING; MATERNAL MORTALITY; MATERNAL TUBERCULOSIS; MATERNAL WELFARE; MYCOBACTERIUM TUBERCULOSIS; NIGHT SWEAT; PREGNANT WOMAN; PREVENTIVE HEALTH SERVICE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; PUBLIC HEALTH SERVICE; REVIEW; SHORT COURSE THERAPY; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TUBERCULOSIS; WEIGHT REDUCTION;

ADULT; ANTITUBERCULAR AGENTS; CHILD; CHILD HEALTH SERVICES; FEMALE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MATERNAL HEALTH SERVICES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TUBERCULOSIS; WORLD HEALTH;

EID: 84860387567     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis009     Document Type: Review

References (113)

1. World Health Organization. Global tuberculosis control: surveillance, planning, financing. Geneva, Switzerland: World Health Organization, 2011.
2. Lonnroth K, Castro KG, Chakaya JM, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010; 375:1814-29.
3. Raviglione MC, Uplekar MW. WHO's new Stop TB strategy. Lancet 2006; 367:952-5.
4. Glaziou P, Floyd K, Korenromp EL, et al. Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Bull World Health Organ 2011; 89:573-82.
5. Getahun H, Raviglione M. Transforming the global tuberculosis response through effective engagement of civil society organizations: the role of the World Health Organization. Bull World Health Organ 2011; 89:616-18.
6. Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B. Paediatric tuberculosis. Lancet Infect Dis 2008; 8:498-510.
7. World Health Organization. Tuberculosis prevalence surveys: a handbook. Geneva, Switzerland: World Health Organization, 2011.
8. Marais BJ, Gupta A, Starke JR, El Sony A. Tuberculosis in women and children. Lancet 2010; 375:2057-9.
9. World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva, Switzerland: World Health Organization, 2006.
10. Harries AD, Hargreaves NJ, Graham SM, et al. Childhood tuberculosis in Malawi: nationwide case-finding and treatment outcomes. Int J Tuberc Lung Dis 2002; 6:424-31.
11. Marais BJ, Hesseling AC, Gie RP, Schaaf HS, Beyers N. The burden of childhood tuberculosis and the accuracy of community-based surveillance data. Int J Tuberc Lung Dis 2006; 10:259-63.
12. Kumar A, Upadhyay S, Kumari G. Clinical presentation, treatment outcome and survival among the HIV infected children with culture confirmed tuberculosis. Curr HIV Res 2007; 5:499-504.
13. Ghritlaharey RK, Budhwani KS, Shrivastava DK. Exploratory laparotomy for acute intestinal conditions in children: a review of 10 years of experience with 334 cases. Afr J Paediatr Surg 2011; 8:62-9.
14. Whittaker E, Kampmann B. Perinatal tuberculosis: new challenges in the diagnosis and treatment of tuberculosis in infants and the newborn. Early Hum Dev 2008; 84:795-9.
15. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva, Switzerland: World Health Organization, 2010.
16. Schaaf HS, Marais BJ, Hesseling AC, Brittle W, Donald PR. Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africadan upward trend. Am J Public Health 2009; 99:1486-90.
17. Thomas TA, Shenoi SV, Heysell SK, et al. Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa. Int J Tuberc Lung Dis 2010; 14:1244-51.
18. Chintu C, Mudenda V, Lucas S, et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet 2002; 360:985-90.
19. Viani RM, Araneta MR, Lopez G, Chacon-Cruz E, Spector SA. Clinical outcomes and hospitalizations among children perinatally infected with HIV-1 in Baja California, Mexico. J Int Assoc Physicians AIDS Care (Chic) 2011; 10:223-8.
20. Wiseman CA, Schaaf HS, Cotton MF, et al. Bacteriologically confirmed tuberculosis in HIV-infected infants: disease spectrum and survival. Int J Tuberc Lung Dis 2011; 15:770-5.
21. Getahun H, Harrington M, O'Brien R, Nunn P. Diagnosis of smearnegative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 2007; 369:2042-9.
22. Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004; 8:636-47.
23. World Health Organization. Rapid advice. Treatment of tuberculosis in children. Geneva, Switzerland: World Health Organization, 2010.
24. World Health Organization. Guidance for national tuberculosis and HIV programmes on the management of tuberculosis in HIVinfected children: recommendations for a public health approach. Geneva, Switzerland: World Health Organization and the International Union Against TB and Lung Diseases, 2010.
25. Lienhardt C, Sillah J, Fielding K, et al. Risk factors for tuberculosis infection in children in contact with infectious tuberculosis cases in The Gambia, West Africa. Pediatrics 2003; 111:e608-14.
26. SinghM, Saini AG, Anil N, Aggarwal A. Latent tuberculosis in children: diagnosis and management. Indian J Pediatr 2011; 78:464-8.
27. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the prechemotherapy era. Int J Tuberc Lung Dis 2004; 8:392-402.
28. Marais BJ. Childhood tuberculosis: epidemiology and natural history of disease. Indian J Pediatr 2011; 78:321-7.
29. Sterne JA, Rodrigues LC, Guedes IN. Does the efficacy of BCG decline with time since vaccination? Int J Tuberc Lung Dis 1998; 2:200-7.
30. Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a metaanalysis and assessment of cost-effectiveness. Lancet 2006; 367: 1173-80.
31. Hesseling AC, Rabie H, Marais BJ, et al. Bacille Calmette-Guerin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis 2006; 42:548-58.
32. Hesseling AC, Johnson LF, Jaspan H, et al. Disseminated bacille Calmette-Guerin disease in HIV-infected South African infants. Bull World Health Organ 2009; 87:505-11.
33. World Health Organization. Revised BCG vaccination guidelines for infants at risk for HIV infection. Wkly Epidemiol Rec 2007; 82: 193-6.
34. Ling DI, Zwerling AA, Steingart KR, Pai M. Immune-based diagnostics for TB in children: what is the evidence? Paediatr Respir Rev 2011; 12:9-15.
35. World Health Organization. Use of interferon gamma release assays (IGRAs) in tuberculosis control in low and middle income countries. Geneva, Switzerland: World Health Organization, 2011.
36. World Health Organization. Guidelines for intensified tuberculosis case finding and isoniazid preventive therapy for people living with HIV in resource constrained settings. Geneva, Switzerland: World Health Organization, 2010.
37. Zar HJ, Cotton MF, Strauss S, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ 2007; 334:136.
38. Madhi SA, Nachman S, Violari A, et al. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med 2011; 365:21-31.
39. Frigati LJ, Kranzer K, Cotton MF, Schaaf HS, Lombard CJ, Zar HJ. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting. Thorax 2011; 66:496-501.
40. Martinson NA, Moultrie H, van Niekerk R, et al. HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort. Int J Tuberc Lung Dis 2009; 13:862-7.
41. Getahun H, Granich R, Sculier D, et al. Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions. AIDS 2010; 24(Suppl 5):S57-65.
42. Marais BJ, van Zyl S, Schaaf HS, van Aardt M, Gie RP, Beyers N. Adherence to isoniazid preventive chemotherapy: a prospective community based study. Arch Dis Child 2006; 91:762-5.
43. Banu Rekha VV, Jagarajamma K, Wares F, Chandrasekaran V, Swaminathan S. Contact screening and chemoprophylaxis in India's Revised Tuberculosis Control Programme: a situational analysis. Int J Tuberc Lung Dis 2009; 13:1507-12.
44. Zachariah R, Spielmann MP, Harries AD, et al. Passive versus active tuberculosis case finding and isoniazid preventive therapy among household contacts in a rural district of Malawi. Int J Tuberc Lung Dis 2003; 7:1033-9.
45. Pothukuchi M, Nagaraja SB, Kelamane S, Satyanarayana S, Shashidhar Babu S, et al. Tuberculosis contact screening and isoniazid preventive therapy in a South Indian district: operational issues for programmatic consideration. PLoS One 2011; 6:e22500.
46. Coulter JB. Diagnosis of pulmonary tuberculosis in young children. Ann Trop Paediatr 2008; 28:3-12.
47. Stockdale AJ, Duke T, Graham S, Kelly J. Evidence behind the WHO guidelines: hospital care for children: what is the diagnostic accuracy of gastric aspiration for the diagnosis of tuberculosis in children? J Trop Pediatr 2010; 56:291-8.
48. Zar HJ, Hanslo D, Apolles P, Swingler G, Hussey G. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 2005; 365:130-4.
49. Moore HA, Apolles P, de Villiers PJ, Zar HJ. Sputum induction for microbiological diagnosis of childhood pulmonary tuberculosis in a community setting. Int J Tuberc Lung Dis 2011; 15: 1185-90, i.
50. Nicol MP, Zar HJ. New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects. Paediatr Respir Rev 2011; 12:16-21.
51. Graham et al. Evaluation of TB diagnostics in children: 1. Proposed clinical case definitions for classification of intra-thoracic tuberculosis disease. Consensus from an Expert Panel. J Infect Dis 2012; 205(Suppl 2):S199-208.
52. Hesseling AC, Schaaf HS, Gie RP, Starke JR, Beyers N. A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int J Tuberc Lung Dis 2002; 6:1038-45.
53. Nicol MP, Workman L, Isaacs W, et al. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 2011; 11:819-24.
54. World Health Organization. Treatment of tuberculosis guidelines. 4th ed. Geneva, Switzerland: World Health Organization, 2009.
55. Menon PR, Lodha R, Sivanandan S, Kabra SK. Intermittent or daily short course chemotherapy for tuberculosis in children: metaanalysis of randomized controlled trials. Indian Pediatr 2011; 47:67-73.
56. Graham SM. Treatment of paediatric TB: revised WHO guidelines. Paediatr Respir Rev 2011; 12:22-6.
57. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach, 2010 revision. Geneva, Switzerland: World Health Organization, 2010.
58. World Health Organization. Report of the meeting on TB medicines for children. WHO headquarters. Geneva, Switzerland: World Health Organization, 2008; 8-9.
59. Donald PR. Antituberculosis drug-induced hepatotoxicity in children. Pediatr Rep 2011; 3:e16.
60. Lienhardt et al. New drugs for the treatment of tuberculosis: needs, challenges, promise and prospects for the future. J Infect Dis 2012; 205(Suppl 2):S241-9.
61. World Health Organization. Dosing instructions for the use of currently available fixed-dose combination TB medicines for children. Geneva, Switzerland: World Health Organization, 2009. www.stoptb. org/assets/documents/gdf/whatis/ Interim%20Paediatric%20FDCs%20 dosing%20instructions%20for%20prescribers-Sept09. pdf. Accessed 3 January 2012.
62. Holmes CB, Hausler H, Nunn P. A review of sex differences in the epidemiology of tuberculosis. Int J Tuberc Lung Dis 1998; 2:96-104.
63. Begum V, de Colombani P, Das Gupta S, et al. Tuberculosis and patient gender in Bangladesh: sex differences in diagnosis and treatment outcome. Int J Tuberc Lung Dis 2001; 5:604-10.
64. Borgdorff MW, Nagelkerke NJ, Dye C, Nunn P. Gender and tuberculosis: a comparison of prevalence surveys with notification data to explore sex differences in case detection. Int J Tuberc Lung Dis 2000; 4:123-32.
65. Balasubramanian R, Garg R, Santha T, et al. Gender disparities in tuberculosis: report from a rural DOTS programme in south India. Int J Tuberc Lung Dis 2004; 8:323-32.
66. Getahun H, Gunneberg C, Granich R, Nunn P. HIV infectionassociated tuberculosis: the epidemiology and the response. Clin Infect Dis 2010; 50(Suppl 3):S201-7.
67. Deluca A, Chaisson RE, Martinson NA. Intensified case finding for tuberculosis in prevention of mother-to-child transmission programs: a simple and potentially vital addition for maternal and child health. J Acquir Immune Defic Syndr 2009; 50:196-9.
68. Chavhan GB, Hira P, Rathod K, et al. Female genital tuberculosis: hysterosalpingographic appearances. Br J Radiol 2004; 77:164-9.
69. Chow TW, Lim BK, Vallipuram S. The masquerades of female pelvic tuberculosis: case reports and review of literature on clinical presentations and diagnosis. J Obstet Gynaecol Res 2002; 28:203-10.
70. Tripathy SN. Infertility and pregnancy outcome in female genital tuberculosis. Int J Gynaecol Obstet 2002; 76:159-63.
71. Ormerod P. Tuberculosis in pregnancy and the puerperium. Thorax 2001; 56:494-9.
72. Thillagavathie P. Current issues in maternal and perinatal tuberculosis: impact of the HIV-1 epidemic. Semin Neonatol 2000; 5:189-96.
73. Pillay T, Khan M, Moodley J, et al. The increasing burden of tuberculosis in pregnant women, newborns and infants under 6 months of age in Durban, KwaZulu-Natal. S Afr Med J 2001; 91:983-7.
74. Leroy V, Msellati P, Lepage P, et al. Four years of natural history of HIV-1 infection in African women: a prospective cohort study in Kigali (Rwanda), 1988-1993. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9:415-21.
75. Gilks CF, Brindle RJ, Otieno LS, et al. Extrapulmonary and disseminated tuberculosis in HIV-1-seropositive patients presenting to the acute medical services in Nairobi. AIDS 1990; 4:981-5.
76. Espinal MA, Reingold AL, Lavandera M. Effect of pregnancy on the risk of developing active tuberculosis. J Infect Dis 1996; 173:488-91.
77. Pillay T, Khan M, Moodley J, Adhikari M, Coovadia H. Perinatal tuberculosis and HIV-1: considerations for resource-limited settings. Lancet Infect Dis 2004; 4:155-65.
78. Bothamley G. Drug treatment for tuberculosis during pregnancy: safety considerations. Drug Saf 2001; 24:553-65.
79. Jana N, Vasishta K, Jindal SK, Khunnu B, Ghosh K. Perinatal outcome in pregnancies complicated by pulmonary tuberculosis. Int J Gynaecol Obstet 1994; 44:119-24.
80. Jana N, Vasishta K, Saha SC, Ghosh K. Obstetrical outcomes among women with extrapulmonary tuberculosis. N Engl J Med 1999; 341: 645-9.
81. Gupta A, Bhosale R, Kinikar A, et al. Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus. J Infect Dis 2011; 203:358-63.
82. Gupta A, Nayak U, Ram M, et al. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005. Clin Infect Dis 2007; 45:241-9.
83. Khan M, Pillay T, Moodley JM, Connolly CA. Maternal mortality associated with tuberculosis-HIV-1 co-infection in Durban, South Africa. AIDS 2001; 15:1857-63.
84. Ahmed Y, Mwaba P, Chintu C, Grange JM, Ustianowski A, Zumla A. A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as amajor non-obstetric cause of maternal death. Int J Tuberc Lung Dis 1999; 3:675-80.
85. Panchabhai TS, Patil PD, Shah DR, Joshi AS. An autopsy study of maternal mortality: a tertiary healthcare perspective. J Postgrad Med 2009; 55:8-11.
86. Menendez C, Romagosa C, Ismail MR, et al. An autopsy study of maternal mortality in Mozambique: the contribution of infectious diseases. PLoS Med 2008; 5:e44.
87. Nachega J, Coetzee J, Adendorff T, et al. Tuberculosis active casefinding in a mother-to-child HIV transmission prevention programme in Soweto, South Africa. AIDS 2003; 17:1398-400.
88. Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2010; (1):CD000171.
89. Lawn SD, Kranzer K, Wood R. Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings. Clin Chest Med 2009; 30:685-99, viii.
90. Golub JE, Saraceni V, Cavalcante SC, et al. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 2007; 21:1441-8.
91. Golub JE, Pronyk P, Mohapi L, et al. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS 2009; 23:631-6.
92. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000; 161:S221-47.
93. Jonnalagadda S, Lohman Payne B, Brown E, et al. Latent tuberculosis detection by interferon gamma release assay during pregnancy predicts active tuberculosis and mortality in human immunodeficiency virus type 1-infected women and their children. J Infect Dis 2010; 202:1826-35.
94. Getahun H, Kittikraisak W, Heilig CM, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med 2011; 8:e1000391.
95. Gupta A, Chandrasekhar A, Gupte N, et al. Symptom screening among HIV-infected pregnant women is acceptable and has high negative predictive value for active tuberculosis. Clin Infect Dis 2011.
96. Sackoff JE, Pfeiffer MR, Driver CR, Streett LS, Munsiff SS, DeHovitz JA. Tuberculosis prevention for non-US-born pregnant women. Am J Obstet Gynecol 2006; 194:451-6.
97. Sterling TR, Pham PA, Chaisson RE. HIV infection-related tuberculosis: clinical manifestations and treatment. Clin Infect Dis 2010; 50(Suppl 3):S223-30.
98. Ramsay A, Bonnet M, Gagnidze L, Githui W, Varaine F, Guerin PJ. Sputum, sex and scanty smears: new case definition may reduce sex disparities in smear-positive tuberculosis. Int J Tuberc Lung Dis 2009; 13:613-19.
99. Khan MS, Dar O, Sismanidis C, Shah K, Godfrey-Faussett P. Improvement of tuberculosis case detection and reduction of discrepancies between men and women by simple sputum-submission instructions: a pragmatic randomised controlled trial. Lancet 2007; 369:1955-60.
100. Long NH, Diwan VK, Winkvist A. Difference in symptoms suggesting pulmonary tuberculosis among men and women. J Clin Epidemiol 2002; 55:115-20.
101. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363:1005-115.
102. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. Policy statement. Geneva, Switzerland: World Health Organization, 2011.
103. Czeizel AE, RockenbauerM, Olsen J, Sorensen HT. A population-based case-control study of the safety of oral anti-tuberculosis drug treatment during pregnancy. Int J Tuberculosis Lung Dis 2001; 5:564-8.
104. Tabarsi P, Moradi A, Baghaei P, et al. Standardised second-line treatment of multidrug-resistant tuberculosis during pregnancy. Int J Tuberc Lung Dis 2011; 15:547-50.
105. Palacios E, Dallman R, Munoz M, et al. Drug-resistant tuberculosis and pregnancy: treatment outcomes of 38 cases in Lima, Peru. Clin Infect Dis 2009; 48:1413-19.
106. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Geneva, Switzerland: World Health Organization, 2011.
107. World Health Organization. WHO recommended interventions for improving maternal and newborn health. Integrated management of pregnancy and child health. Geneva, Switzerland: World Health Organization, 2009.
108. World Health Organization. Three interlinked patient monitoring systems for HIV care/ART, MCH/PMTCT, and TB/HIV: standardized minimum data set and illustrative tools. Geneva, Switzerland: World Health Organization, 2010.
109. South African Department of Health. Integrated management of childhood illnesses. Pretoria, South Africa: Department of Health, 2009.
110. Donald RR, Maher D, Qazi S. A research agenda to promote the management of childhood tuberculosis within national tuberculosis programmes. Int J Tuberculosis Lung Dis 2007; 11:370-80.
111. Sculier D, Getahun H, Lienhardt C. Improving the prevention, diagnosis and treatment of TB among people living with HIV: the role of operational research. J Int AIDS Soc 2011; 14:S5.
112. Luetkemeyer AF, Getahun H, Chamie G, Lienhardt C, Havlir DV. Tuberculosis drug development: ensuring people living with HIV are not left behind. Am J Respir Crit Care Med 2011.
113. Cobelens FG, Heldal E, Kimerling ME, et al. Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda. PLoS Med 2008; 5:e150.